檢索結果 - Saggese, Matilde

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Advanced gastric cancer: Is there enough evidence to call second-line therapy standard?

    Advanced gastric cancer: Is there enough evidence to call second-line therapy standard? 由 Arkenau, Hendrik-Tobias, Saggese, Matilde, Lemech, Charlotte

    出版 2012
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  2. 2
    Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations

    Research Biopsies in the Context of Early Phase Oncology Studies: Clinical and Ethical Considerations 由 Saggese, Matilde, Dua, Divyanshu, Simmons, Emily, Lemech, Charlotte, Arkenau, Hendrik-Tobias

    出版 2013
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  3. 3
    Interleukin-10 Expression in Macrophages during Phagocytosis of Apoptotic Cells Is Mediated by the TALE homeoproteins Pbx-1 and Prep-1

    Interleukin-10 Expression in Macrophages during Phagocytosis of Apoptotic Cells Is Mediated by the TALE homeoproteins Pbx-1 and Prep-1 由 Chung, Elaine Y., Liu, Jianguo, Homma, Yoichiro, Zhang, Yunhua, Brendolan, Andrea, Saggese, Matilde, Han, Jihong, Silverstein, Roy, Selleri, Licia, Ma, Xiaojing

    出版 2007
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  4. 4
    Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study

    Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study 由 Cheng, Ying, He, Yong, Li, Wei, Zhang, He-long, Zhou, Qing, Wang, Buhai, Liu, Chunling, Walding, Andrew, Saggese, Matilde, Huang, Xiangning, Fan, Minhao, Wang, Jia, Ramalingam, Suresh S.

    出版 2021
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  5. 5
    A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer

    A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer 由 Macpherson, Iain R., Spiliopoulou, Pavlina, Rafii, Saeed, Saggese, Matilde, Baird, Richard D., Garcia-Corbacho, Javier, Italiano, Antoine, Bonneterre, Jacques, Campone, Mario, Cresti, Nicola, Posner, John, Takeda, Yousuke, Arimura, Akinori, Spicer, James

    出版 2019
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  6. 6
    Congenital Asplenia in Mice and Humans with Mutations in a Pbx/Nkx2-5/p15 Module

    Congenital Asplenia in Mice and Humans with Mutations in a Pbx/Nkx2-5/p15 Module 由 Koss, Matthew, Bolze, Alexandre, Brendolan, Andrea, Saggese, Matilde, Capellini, Terence D., Bojilova, Ekaterina, Boisson, Bertrand, Prall, Owen W.J., Elliott, David, Solloway, Mark, Lenti, Elisa, Hidaka, Chisa, Chang, Ching-Pin, Mahlaoui, Nizar, Harvey, Richard P., Casanova, Jean-Laurent, Selleri, Licia

    出版 2012
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:
  7. 7
    Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer

    Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Adv... 由 Gray, Jhanelle E., Okamoto, Isamu, Sriuranpong, Virote, Vansteenkiste, Johan, Imamura, Fumio, Lee, Jong Seok, Pang, Yong-Kek, Cobo, Manuel, Kasahara, Kazuo, Cheng, Ying, Nogami, Naoyuki, Cho, Eun Kyung, Su, Wu Chou, Zhang, Guili, Huang, Xiangning, Li-Sucholeiki, Xiaocheng, Lentrichia, Brian, Dearden, Simon, Jenkins, Suzanne, Saggese, Matilde, Rukazenkov, Yuri, Ramalingam, Suresh S.

    出版 2019
    獲取全文 獲取全文 獲取全文
    Text
    加到收藏夾
    Saved in:

檢索工具: